Back to Search Start Over

Diagnostic Role of Long Non-Coding RNAs in Breast Cancer: a Systematic Review and Meta-Analysis.

Authors :
Xiaojiao Gao
Jianhao Xu
Fang Cao
Fang Chen
Ting Chen
Hai Li
Zhiyong Deng
Song Xu
Source :
Clinical Laboratory; 2021, Vol. 67 Issue 3, p649-659, 11p
Publication Year :
2021

Abstract

Background: Recent research has suggested that long non-coding RNA (lncRNA) is involved in the tumorigenesis and development of breast cancer (BC). This meta-analysis aimed to identify the diagnostic role of lncRNAs in BC. Methods: All relevant studies were systematically searched through PubMed, Web of Science, Cochrane Library, and EMBASE databases. The diagnostic values of lncRNAs were mainly assessed by pooled sensitivity (SEN), specificity (SPE), and summary receiver operating characteristic area under the curve (SROC AUC). Meta-DiSc 1.4, Review Manager 5.3 and STATA 12.0 were used for statistical analysis. Results: A total of 24 eligible studies were included in this meta-analysis. The pooled SEN, SPE, and AUC were 0.75 (95% CI: 0.68 - 0.81), 0.77 (95% CI: 0.70 - 0.82), and 0.82 (95% CI: 0.79 - 0.86), respectively, suggesting that the lncRNAs test had a high accuracy for the diagnosis of BC. Obvious heterogeneity might come from the dysregulated state of lncRNAs through subgroup and meta-regression analysis (p < 0.001). Fagan diagram showed clinical value of lncRNAs test in BC. Conclusions: Abnormal expression of lncRNAs exhibits a high efficacy for diagnosing BC, which is promising in clinical application. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
14336510
Volume :
67
Issue :
3
Database :
Complementary Index
Journal :
Clinical Laboratory
Publication Type :
Academic Journal
Accession number :
149427867
Full Text :
https://doi.org/10.7754/Clin.Lab.2020.200662